Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


| Molecular Weight | 326.8 g/mol |
|---|---|
| Molecular Formula | C18H19ClN4 |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 326.1298243 g/mol |
| Monoisotopic Mass | 326.1298243 g/mol |
| Topological Polar Surface Area | 30.9 A^2 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 584 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 6 | |
|---|---|
| Drug Name | Clozapine |
| PubMed Health | Clozapine (By mouth) |
| Drug Classes | Antipsychotic |
| Drug Label | VERSACLOZ, an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine.The structural formula is: VERSACLOZ is available as a free-flowing yellow suspension. Each mL c... |
| Active Ingredient | Clozapine |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 200mg; 100mg; 25mg; 50mg; 12.5mg |
| Market Status | Prescription |
| Company | Ivax Sub Teva Pharms; Sun Pharm Inds; Mylan |
| 2 of 6 | |
|---|---|
| Drug Name | Clozaril |
| PubMed Health | Clozapine (By mouth) |
| Drug Classes | Antipsychotic |
| Drug Label | CLOZARIL (clozapine), an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo [b,e] [1,4] diazepine.The structural formula isCLOZARIL is available in pale yellow tablets of 25mg... |
| Active Ingredient | Clozapine |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 100mg; 25mg |
| Market Status | Prescription |
| Company | Novartis |
| 3 of 6 | |
|---|---|
| Drug Name | Fazaclo odt |
| Active Ingredient | Clozapine |
| Dosage Form | Tablet, orally disintegrating |
| Route | Oral |
| Strength | 200mg; 100mg; 25mg; 150mg; 12.5mg |
| Market Status | Prescription |
| Company | Jazz Pharms Iii |
| 4 of 6 | |
|---|---|
| Drug Name | Clozapine |
| PubMed Health | Clozapine (By mouth) |
| Drug Classes | Antipsychotic |
| Drug Label | VERSACLOZ, an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine.The structural formula is: VERSACLOZ is available as a free-flowing yellow suspension. Each mL c... |
| Active Ingredient | Clozapine |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 200mg; 100mg; 25mg; 50mg; 12.5mg |
| Market Status | Prescription |
| Company | Ivax Sub Teva Pharms; Sun Pharm Inds; Mylan |
| 5 of 6 | |
|---|---|
| Drug Name | Clozaril |
| PubMed Health | Clozapine (By mouth) |
| Drug Classes | Antipsychotic |
| Drug Label | CLOZARIL (clozapine), an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo [b,e] [1,4] diazepine.The structural formula isCLOZARIL is available in pale yellow tablets of 25mg... |
| Active Ingredient | Clozapine |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 100mg; 25mg |
| Market Status | Prescription |
| Company | Novartis |
| 6 of 6 | |
|---|---|
| Drug Name | Fazaclo odt |
| Active Ingredient | Clozapine |
| Dosage Form | Tablet, orally disintegrating |
| Route | Oral |
| Strength | 200mg; 100mg; 25mg; 150mg; 12.5mg |
| Market Status | Prescription |
| Company | Jazz Pharms Iii |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37540
Submission : 2023-02-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11195
Submission : 1994-11-16
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19822
Submission : 2006-10-02
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2023-01-26
Pay. Date : 2022-12-12
DMF Number : 36645
Submission : 2021-12-23
Status : Active
Type : II
Certificate Number : CEP 2023-444 - Rev 00
Issue Date : 2024-03-28
Type : Chemical
Substance Number : 1191
Status : Valid
Date of Issue : 2022-09-12
Valid Till : 2025-08-12
Written Confirmation Number : WC-0542
Address of the Firm :

GDUFA
DMF Review : Reviewed
Rev. Date : 2013-11-04
Pay. Date : 2013-08-27
DMF Number : 27379
Submission : 2013-09-17
Status : Active
Type : II
Date of Issue : 2023-05-10
Valid Till : 2026-05-10
Written Confirmation Number : WC-0015
Address of the Firm :

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38071
Submission : 2023-03-09
Status : Active
Type : II
Date of Issue : 2025-09-08
Valid Till : 2028-07-07
Written Confirmation Number : WC-0445
Address of the Firm :
NDC Package Code : 71554-025
Start Marketing Date : 2021-01-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2014-08-29
Pay. Date : 2013-09-25
DMF Number : 25182
Submission : 2011-08-03
Status : Active
Type : II
Certificate Number : R1-CEP 2012-006 - Rev 00
Issue Date : 2018-04-12
Type : Chemical
Substance Number : 1191
Status : Valid
NDC Package Code : 64374-004
Start Marketing Date : 2016-07-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39913
Submission : 2024-05-28
Status : Active
Type : II
Date of Issue : 2025-07-07
Valid Till : 2028-07-21
Written Confirmation Number : WC-0373
Address of the Firm :
NDC Package Code : 67835-0028
Start Marketing Date : 2021-09-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
21
PharmaCompass offers a list of Clozapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Clozapine manufacturer or Clozapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clozapine manufacturer or Clozapine supplier.
A Clorazil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clorazil, including repackagers and relabelers. The FDA regulates Clorazil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clorazil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clorazil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Clorazil supplier is an individual or a company that provides Clorazil active pharmaceutical ingredient (API) or Clorazil finished formulations upon request. The Clorazil suppliers may include Clorazil API manufacturers, exporters, distributors and traders.
click here to find a list of Clorazil suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Clorazil DMF (Drug Master File) is a document detailing the whole manufacturing process of Clorazil active pharmaceutical ingredient (API) in detail. Different forms of Clorazil DMFs exist exist since differing nations have different regulations, such as Clorazil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clorazil DMF submitted to regulatory agencies in the US is known as a USDMF. Clorazil USDMF includes data on Clorazil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clorazil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clorazil suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Clorazil Drug Master File in Japan (Clorazil JDMF) empowers Clorazil API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Clorazil JDMF during the approval evaluation for pharmaceutical products. At the time of Clorazil JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Clorazil suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clorazil Drug Master File in Korea (Clorazil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clorazil. The MFDS reviews the Clorazil KDMF as part of the drug registration process and uses the information provided in the Clorazil KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clorazil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clorazil API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clorazil suppliers with KDMF on PharmaCompass.
A Clorazil CEP of the European Pharmacopoeia monograph is often referred to as a Clorazil Certificate of Suitability (COS). The purpose of a Clorazil CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clorazil EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clorazil to their clients by showing that a Clorazil CEP has been issued for it. The manufacturer submits a Clorazil CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clorazil CEP holder for the record. Additionally, the data presented in the Clorazil CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clorazil DMF.
A Clorazil CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clorazil CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clorazil suppliers with CEP (COS) on PharmaCompass.
A Clorazil written confirmation (Clorazil WC) is an official document issued by a regulatory agency to a Clorazil manufacturer, verifying that the manufacturing facility of a Clorazil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clorazil APIs or Clorazil finished pharmaceutical products to another nation, regulatory agencies frequently require a Clorazil WC (written confirmation) as part of the regulatory process.
click here to find a list of Clorazil suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clorazil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clorazil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clorazil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clorazil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clorazil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clorazil suppliers with NDC on PharmaCompass.
Clorazil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clorazil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Clorazil GMP manufacturer or Clorazil GMP API supplier for your needs.
A Clorazil CoA (Certificate of Analysis) is a formal document that attests to Clorazil's compliance with Clorazil specifications and serves as a tool for batch-level quality control.
Clorazil CoA mostly includes findings from lab analyses of a specific batch. For each Clorazil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clorazil may be tested according to a variety of international standards, such as European Pharmacopoeia (Clorazil EP), Clorazil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clorazil USP).